Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
14
pubmed:dateCreated
2005-12-1
pubmed:abstractText
Ubiquitin-proteasome system (UPS) mediated proteolysis is responsible for the degradation of majority of cellular proteins, thereby playing essential roles in maintaining cellular homeostasis and regulating a number of cellular functions. UPS dysfunction was implicated in the pathogenesis of numerous disorders, including neurodegenerative disease, muscular dystrophy, and a subset of cardiomyopathies. However, monitoring in vivo functional changes of the UPS remains a challenge, which hinders the elucidation of UPS pathophysiology. We have recently created a novel transgenic mouse model that ubiquitously expresses a surrogate protein substrate for the UPS. The present study validates its suitability to monitor in vivo changes of UPS proteolytic function in virtually all major organs. Primary culture of cells derived from the adult transgenic mice was also developed and tested for their applications in probing UPS involvement in pathogenesis. Applying these newly established in vivo and in vitro approaches, we have proven in the present study that doxorubicin enhances UPS function in the heart and in cultured cardiomyocytes, suggesting that UPS hyper-function may play an important role in the acute cardiotoxicity of doxorubicin therapy.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1530-6860
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2051-3
pubmed:dateRevised
2011-1-26
pubmed:meshHeading
pubmed-meshheading:16188962-Animals, pubmed-meshheading:16188962-Antibiotics, Antineoplastic, pubmed-meshheading:16188962-Cell Line, pubmed-meshheading:16188962-Doxorubicin, pubmed-meshheading:16188962-Echocardiography, pubmed-meshheading:16188962-Electrophoresis, Polyacrylamide Gel, pubmed-meshheading:16188962-Genotype, pubmed-meshheading:16188962-Green Fluorescent Proteins, pubmed-meshheading:16188962-Heart, pubmed-meshheading:16188962-Humans, pubmed-meshheading:16188962-Mice, pubmed-meshheading:16188962-Mice, Transgenic, pubmed-meshheading:16188962-Microscopy, Fluorescence, pubmed-meshheading:16188962-Models, Biological, pubmed-meshheading:16188962-Myocardium, pubmed-meshheading:16188962-Myocytes, Cardiac, pubmed-meshheading:16188962-Protease Inhibitors, pubmed-meshheading:16188962-Proteasome Endopeptidase Complex, pubmed-meshheading:16188962-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16188962-Spectrometry, Fluorescence, pubmed-meshheading:16188962-Time Factors, pubmed-meshheading:16188962-Ubiquitin
pubmed:year
2005
pubmed:articleTitle
A novel transgenic mouse model reveals deregulation of the ubiquitin-proteasome system in the heart by doxorubicin.
pubmed:affiliation
Cardiovascular Research Institute, South Dakota Health Research Foundation, Sioux Falls, South Dakota 57105, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural